investor seagen.com

Seattle Genetics, Inc. Investors News Investors News

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates ADCs, a technology designed to. 160;0330.73. 5,596,432,697. 080715400 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 073015430 pmET.
traffic

OVERVIEW

The site investor.seagen.com currently has a traffic ranking of zero (the lower the more traffic). We have detected three social media platforms linked to investor.seagen.com.
Social Links
3

INVESTOR.SEAGEN.COM TRAFFIC

The site investor.seagen.com has seen varying levels of traffic in the past the year.
Traffic for investor.seagen.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.seagen.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.seagen.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO INVESTOR.SEAGEN.COM

WHAT DOES INVESTOR.SEAGEN.COM LOOK LIKE?

Desktop Screenshot of investor.seagen.com Mobile Screenshot of investor.seagen.com Tablet Screenshot of investor.seagen.com

INVESTOR.SEAGEN.COM SERVER

We observed that the main page on investor.seagen.com took zero milliseconds to load. We could not observe a SSL certificate, so in conclusion our parsers consider investor.seagen.com not secure.
Load time
0 sec
SSL
NOT SECURE
IP
23.12.41.8

SITE TITLE

Seattle Genetics, Inc. Investors News Investors News

DESCRIPTION

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates ADCs, a technology designed to. 160;0330.73. 5,596,432,697. 080715400 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 073015430 pmET.

PARSED CONTENT

The site investor.seagen.com had the following on the web site, "Transforming cancer treatment and advancing new therapies through empowered science." I noticed that the webpage said " Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer." They also stated " We are the industry leader in antibody-drug conjugates ADCs, a technology designed to. Seattle Genetics Reports Second Quarter 2015 Financial Results."

SEE MORE DOMAINS

SEBI Investor Home

View articles for various topics. Information to public on complaints. Scheme for conduct of Awareness Programs for Commodities Derivatives. National Strategy for Financial Education. Securities and Exchange Board of India. Insurance Regulatory and Development Authority. Listed Companies Status - SCORES.

浙江森马服饰股份有限公司-投资者关系

森马服饰 2012 年 2014 年股东回报规划.

Senomyx Investor Relations Home - Investor Relations - Senomyx

SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS. Second Quarter 2015 Earnings Conference Call Scheduled for July 30, 2015. SENOMYX ANNOUNCES CONTINUED INCLUSION IN THE RUSSELL 2000 AND RUSSELL 3000 INDEXES. SENOMYX ANNOUNCES FIRST QUARTER 2015 FINANCIAL RESULTS. Data Provided by Thomson Reuters.

Home - The Apptix Investor Web Site

Kjetil Askildsen VP of Corporate Development and Investor Relations. APPTIX ANNOUNCES AVAILABILITY OF WEBMESSENGER MESSAGE ALERTS FOR BLACKBERRY. APPTIX JOINS BLACKBERRY ALLIANCE PROGRAM AS A SYSTEM INTEGRATOR GOLD PARTNER. APPTIX ADOPTS MICROSOFT HMC 4. 0 FOR ITS HOSTED EXCHANGE 2007 SERVICE. PROSPECTUS APPROVED BY OSLO STOCK EXCHANGE.

INVESTOR RELATIONS Sharps Compliance Corporation

Containers, Mounts and Other. Nationwide provider of healthcare waste solutions for small to mid-size quantity generators.